review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1007/BF03324857 |
P698 | PubMed publication ID | 18852539 |
P50 | author | Paolo Tonin | Q42747028 |
Stefania Maggi | Q114171748 | ||
P2093 | author name string | Gaetano Crepaldi | |
Alois Saller | |||
Giovanna Romanato | |||
P2860 | cites work | Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 | Q27860575 |
Osteoblast-derived cells express functional glucose-dependent insulinotropic peptide receptors | Q28145693 | ||
Identifying bone-mass-related risk factors for fracture to guide bone densitometry measurements: a systematic review of the literature | Q30765771 | ||
Worldwide increase in incidence of Type I diabetes--the analysis of the data on published incidence trends | Q31473026 | ||
Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspective | Q33913377 | ||
Osteoprotegerin ligand: a regulator of immune responses and bone physiology. | Q34079327 | ||
Who has osteoporosis? A conflict between clinical and public health perspectives | Q34111545 | ||
Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. | Q34319046 | ||
Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994. | Q34466568 | ||
Role of adipose tissue as an inflammatory organ in human diseases | Q34523574 | ||
Long-term bone loss in insulin-dependent diabetes mellitus | Q34589435 | ||
Bone is a target for the antidiabetic compound rosiglitazone. | Q35758012 | ||
Adipose tissue, inflammation, and cardiovascular disease | Q36125401 | ||
Potential role of pancreatic and enteric hormones in regulating bone turnover. | Q36214176 | ||
Rising incidence of insulin dependent diabetes in children aged under 5 years in the Oxford region: time trend analysis. The Bart's-Oxford Study Group | Q36246394 | ||
Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues | Q36281802 | ||
Osteoporosis in type II diabetes | Q36457241 | ||
HMG-CoA reductase inhibitors and the risk of fractures | Q38496425 | ||
Quantitative heel ultrasound in a population-based study in Italy and its relationship with fracture history: the ESOPO study | Q38513084 | ||
Osteopenia and diabetes. | Q39487558 | ||
The hypercalciuria of diabetes mellitus: its amelioration with insulin | Q40188776 | ||
Transgenic mice with osteoblast-targeted insulin-like growth factor-I show increased bone remodeling | Q40286652 | ||
Mosaic analysis of insulin receptor function | Q40413498 | ||
World-wide projections for hip fracture | Q40909953 | ||
Effects of Diabetes Mellitus on Bone Mass in Juvenile and Adult-Onset Diabetes | Q41076132 | ||
Bone mineral density and bone metabolism in diabetes mellitus | Q41710701 | ||
Epidemiology of hip fractures | Q41717622 | ||
Bone mineral density at time of clinical diagnosis of adult-onset type 1 diabetes mellitus | Q42510908 | ||
Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation | Q43583991 | ||
Decreased bone mineral density and bone formation markers shortly after diagnosis of clinical type 1 diabetes mellitus. | Q43630701 | ||
Diabetes and risk of fracture: The Blue Mountains Eye Study | Q43651870 | ||
Prevalence of low femoral bone density in older U.S. adults from NHANES III. | Q44113237 | ||
Role of gastrointestinal hormones in postprandial reduction of bone resorption | Q44691059 | ||
Body composition and bone mineral density in long-standing type 1 diabetes | Q44761590 | ||
Risk factors and health determinants in older Italians | Q44887368 | ||
Osteopenia in insulin treated diabetes mellitus. Its relation to age at onset, sex and duration of disease | Q45026095 | ||
Diabetes mellitus and the incidence of hip fracture: results from the Nord-Trøndelag Health Survey | Q45058945 | ||
Bone mineral density in children and adolescents with diabetes mellitus type 1 of recent onset | Q45238101 | ||
Sex differences in osteoporosis in older adults with non-insulin-dependent diabetes mellitus | Q45937461 | ||
Bone mineral metabolism is normal in non-insulin-dependent diabetes mellitus | Q46293407 | ||
Serum levels of insulin-like growth factor system components and relationship to bone metabolism in Type 1 and Type 2 diabetes mellitus patients | Q46413037 | ||
Older women with diabetes have an increased risk of fracture: a prospective study | Q46556380 | ||
Glucose-dependent insulinotropic peptide is an integrative hormone with osteotropic effects. | Q48866872 | ||
Increase in incidence of insulin-dependent diabetes mellitus among children in Finland. | Q50610289 | ||
Bone mineral density and blood flow to the lower extremities: the study of osteoporotic fractures. | Q50619843 | ||
Analysis of 20 years of prospective registration of childhood onset diabetes time trends and birth cohort effects. Swedish Childhood Diabetes Study Group. | Q50667674 | ||
Trends in the incidence of childhood-onset diabetes in Europe 1989-1998. | Q50687950 | ||
Prospective bone mineral density evaluation in patients with insulin-dependent diabetes mellitus. | Q50883815 | ||
Increasing serum osteocalcin after glycemic control in diabetic men. | Q51584402 | ||
The association of obesity and glucose and insulin concentrations with bone density in premenopausal and postmenopausal women. | Q51600199 | ||
An evaluation of bone density and turnover in premenopausal women with type 1 diabetes mellitus. | Q51601847 | ||
The relationships of concentrations of insulin, intact proinsulin and 32-33 split proinsulin with cardiovascular risk factors in type 2 (non-insulin-dependent) diabetic subjects. | Q51614436 | ||
Bone Density in Non-Insulin-Dependent Diabetes Mellitus: The Rotterdam Study | Q57388854 | ||
Leptin Inhibits Osteoclast Generation | Q57533678 | ||
Letters to the Editors | Q58868275 | ||
P433 | issue | 4 | |
P921 | main subject | osteoporosis | Q165328 |
P304 | page(s) | 280-289 | |
P577 | publication date | 2008-08-01 | |
P1433 | published in | Aging Clinical and Experimental Research | Q15754191 |
P1476 | title | Diabetes and osteoporosis | |
P478 | volume | 20 |
Q35955946 | Alteration of vitamin D metabolic enzyme expression and calcium transporter abundance in kidney involved in type 1 diabetes-induced bone loss |
Q89516735 | Antidiabetic and antiosteoporotic pharmacotherapies for prevention and treatment of type 2 diabetes-induced bone disease: protocol for two network meta-analyses |
Q36028626 | Association between bone mineral density and type 2 diabetes mellitus: a meta-analysis of observational studies |
Q37319080 | Association between osteoprotegerin G1181C and T245G polymorphisms and diabetic charcot neuroarthropathy: a case-control study |
Q41733140 | Association of haematological parameters with bone mineral density in elderly diabetic women |
Q35137241 | Diabetes reduces mesenchymal stem cells in fracture healing through a TNFα-mediated mechanism |
Q51298932 | Effect of exenatide, insulin and pioglitazone on bone metabolism in patients with newly diagnosed type 2 diabetes. |
Q96432958 | Effects of Glycated Hemoglobin Level on Bone Metabolism Biomarkers in Patients with Type 2 Diabetes Mellitus |
Q35212798 | Elevated incidence of fractures in solid-organ transplant recipients on glucocorticoid-sparing immunosuppressive regimens |
Q52702566 | Imaging of diabetic bone. |
Q28567293 | Insulin receptor substrate 2 plays important roles in 17beta-estradiol-induced bone formation |
Q37899709 | Osteoporosis and risk of fracture in patients with diabetes: an update |
Q36582730 | Prevalence of Osteoporosis and Its Associated Factors among Older Men with Type 2 Diabetes |
Q58588725 | The Effects of Soy Milk Enriched with Lactobacillus casei and Omega-3 on the Tibia and L5 Vertebra in Diabetic Rats: a Stereological Study |
Q38233593 | The prevention of fragility fractures in diabetic patients. |